RxNorm Names
Not yet provided
ZICAM
(zinc acetate and zinc gluconate)
tablet, orally disintegrating
[Matrixx Initiatives, Inc.]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba3cfc70-cead-489c-bf79-59774cf22fee| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | unapproved homeopathic |
NOTE:THIS HOMEOPATHIC PRODUCT HAS NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION FOR SAFETY OR EFFICACY. FDA IS NOT AWARE OF SCIENTIFIC EVIDENCE TO SUPPORT HOMEOPATHY AS EFFECTIVE.
Uses
- reduces duration of a cold
- reduces severity of cold symptoms:
- sore throat
- stuffy nose
- sneezing
- coughing
- congestion
Warnings
Directions
- For best results, use at the first sign of a cold and continue to use for an additional 48 hours after symptoms subside.
- Adults and children 12 years of age and older:
- Dissolve entire tablet in mouth. Do not chew. Do not swallow whole.
- Take 1 tablet at the onset of symptoms.
- Repeat every 3 hours until symptoms are gone.
- To avoid minor stomach upset, do not take on an empty stomach.
- Do not eat or drink for 15 minutes after use. Do not eat or drink citrus fruits or juices for 30 minutes before or after use. Otherwise, drink plenty of fluids.
- Children under 12 years of age: Consult a doctor before use.
Inactive ingredients
artificial cherry flavor, crospovidone, magnesium stearate, mannitol, mono-ammonium glycyrrhizinate, sodium starch glycolate, stearic acid, sucralose
| ZICAM
zinc acetate and zinc gluconate tablet, orally disintegrating |
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
| Labeler - Matrixx Initiatives, Inc. (790037253) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Nutritional Labs International | 007306970 | Manufacture | |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Boston Analytical, Inc. | 147830830 | Analysis | |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| TLC Labs, Inc | 169896730 | Analysis | |
Revised: 02/2011
Document Id: 115a323d-f166-4584-9946-2327afcecaec
Set id: ba3cfc70-cead-489c-bf79-59774cf22fee
Version: 3
Effective Time: 20110215
Matrixx Initiatives, Inc.
